FDA Faces Uncertainty Implementing 21st Century Cures Act

Law360, New York (March 15, 2017, 12:11 PM EDT) -- Seth D. Rothman

Jessica Studness One of the last bills President Barack Obama signed into law was the 21st Century Cures Act, sweeping legislation intended to accelerate the development and delivery of "21st century cures." The act promotes innovative projects, supports state efforts to curb opioid abuse, promotes the discovery of new medical products, and accelerates U.S. Food and Drug Administration approval of new medicines and medical devices. 

The act sailed through Congress with broad bipartisan support, and the FDA stood ready to implement its provisions. Three months later, however, uncertainties created by two presidential actions — the 90-day hiring freeze...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Beta
Ask a question!